BSECompany Update12 Aug 2026 · 12 Aug 2026, 08:03 pm
Please find enclosed herewith the outcome of Members of the Nomination and Remuneration Committee of Bliss GVS Pharma Limited ("the Company")in its meeting held today i.e. on August 12, ....
Bliss GVS Pharma Ltd · 506197
✦ AI Summary
Bliss GVS Pharma Ltd granted 3,20,000 stock options under Employee Stock Options Plan 2019 to eligible employees, with vesting in 4 instalments over 48 months, and a lock-in period of 6 months from allotment of equity shares.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Bliss GVS Pharma Ltd - 506197 - Grant Of Options Under Bliss GVS Pharma Limited - Employee Stock Options Plan 2019
Attachments (1)
📄pdf
Download →
733accd5-ec86-464e-9891-a80b686bbfef.pdf
View document text
August 12, 2026
To To
The Manager, Listing Department The General Manager, Listing Department
National Stock Exchange of India Ltd. BSE Limited
Plot no. C/1 G Block, Phiroze Jeejeebhoy Towers,
Bandra-Kurla Complex, Bandra (East), Dalal Street,
Mumbai- 400 051 Mumbai- 400 001
Symbol: BLISSGVS Scrip Code: 506197
Dear Sir/Madam,
Subject: Grant of Options under Bliss GVS Pharma Limited – Employee Stock Options
Plan 2019
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015 ('SEBI Listing Regulations') read with Schedule III of SEBI Listing
Regulations, we would like to inform you that, the Members of the Nomination and
Remuneration Committee of Bliss GVS Pharma Limited (“the Company”) in its meeting
held today i.e. on August 12, 2026 has granted 3,20,000 (Three Lakh Twenty Thousand)
Stock Options under Bliss GVS Pharma Limited– Employee Stock Options Plan 2019 to
the eligible employees of the Company.
Required details under SEBI Master Circular No. HO/49/14/14(7)2025-CFD-
POD2/I/3762/2026 dated January 30, 2026, read with SEBI Circular SEBI/HO/CFD/CFD-
PoD-1/P/CIR/2023/123 dated July 13, 2023, is enclosed.
You are requested to take the aforementioned information for your records.
Thanking you.
Yours faithfully,
For Bliss GVS Pharma Limited
Aditi Bhatt
Company Secretary
End: a/a
Sr. No. Particulars Details
a) Brief Details of Options Granted 3,20,000 (Three Lakh Twenty Thousand)
Stock Options were granted under Bliss
GVS Pharma Limited – Employee Stock
Options Plan 2019 by the Nomination and
Remuneration Committee.
b) Whether the scheme is in terms of Yes
SEBI (SBEB) Regulations, 2014/
SEBI (SBEBSE) Regulations, 2021
(if applicable)
c) Total number of shares covered by 3,20,000 (Three Lakh Twenty
these options Thousand) equity shares of Re. 1/- each
(Each stock option is convertible into the
equivalent number of shares of the face
value of Re. 1/- each).
d) Pricing formula Exercise Price of Rs. 43/- per option/per
share based upon the BSE Last Closing
Market price dated August 11, 2026, after
deducting 91.32% discount and as
determined by the Members of the
Nomination and Remuneration
Committee to bring uniformity in the
exercise price of earlier options granted
by the Company.
e) Options Vested Not Applicable
f) Time within which option may be The vested options shall be exercisable
exercised within a period of 6 months from the date
of vesting of such options.
g) Options exercised Not Applicable
h) Money realized by exercise of Not Applicable
options
i) The total number of shares arising Not Applicable
as a result of exercise of option
j) Options lapsed Not Applicable
k) Variation of terms of options Not Applicable
l) Brief details of significant terms i) The Options granted would Vest in to the
Eligible Employee in 4 (four) instalments
in the following manner:
a) 25% of the total number of Options
granted after 12 months, from the date of
Grant of Options.
b) 25% of the total number of Options
granted after 24 months, from the date of
Grant of Options.
c) 25% of the total number of Options
granted after 36 months, from the date of
Grant of Options.
d) 25% of the total number of Options
granted after 48 months, from the date of
Grant of Options
e) There shall be a minimum period of one
year between the grant of options and
vesting of options.
f) The maximum exercise period for
Exercise of an Option would be six
months from the date of its Vesting.
g) The Equity Shares arising out of Vested
Options under the scheme, shall be
subject to lock-in for a period of 6 (six)
months from the date of allotment of
Equity Shares.
m) Subsequent changes or Not Applicable
cancellation or exercise of such
options
n) Subsequent changes or Not Applicable
cancellation or exercise of such
options